Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | IM / LA |
he began experiencing dizziness; Muscle pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of dizziness in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included blood pressure, benign prostatic hyperplasia and anticoagulant therapy. Concomitant products included nebivolol, morniflumate (Flomax), aspirin, acetylcysteine (N Acetyl Cystein) and collagen. On 02-APR-2025, the patient received Shingrix (intramuscular, left deltoid). On 02-APR-2025, less than a day after receiving Shingrix, the patient experienced muscle pain (Verbatim: Muscle pain). On 04-APR-2025, the patient experienced dizziness (Verbatim: he began experiencing dizziness). The outcome of the dizziness was not resolved and the outcome of the muscle pain was resolved. It was unknown if the reporter considered the dizziness and muscle pain to be related to Shingrix. It was unknown if the company considered the dizziness and muscle pain to be related to Shingrix. Additional Information: GSK Receipt Date: 07-APR-2025 The patient self-reported this case for himself. The patient received his Shingrix vaccine in his left deltoid. He states that two days later he began experiencing dizziness, which was worse when he was lying flat. The patient had seen his primary care physician who performed the Epley maneuver and administered a steroid shot. He also saw a chiropractor and received a neck adjustment. The patient stated that there has been no improvement. He also reported muscle pain which began the day of the vaccination and went away within a couple of days.
Anticoagulant therapy; Benign prostatic hyperplasia; Blood pressure
Nebivolol; Flomax; Aspirin; N Acetyl Cystein; COLLAGEN